Keywords: DLBCL; Surveillance; Relapse; Auto-HCT;
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: asymmetry; cancer; pediatric; tonsil; malignancy; unilateral; DLBCL; Diffuse large B-cell lymphoma; SEER; Surveillance, Epidemiology and End Results (database); UTE; Unilateral tonsillar enlargement;
Keywords: ADC; apparent diffusion coefficient; BMB; bone marrow biopsy; DLBCL; diffuse large B-cell lymphoma; DWI; diffusion-weighted imaging; HL; Hodgkin lymphoma; SUV; standardized uptake value; VOI; volume of interest; WB-DWI; whole-body diffusion-weighted imagi
Keywords: EV; extracellular vesicles; ILVs; intraluminal vesicles; BMSCs; bone marrow stromal cells; AML; acute myeloid leukemia; CML; chronic myelogenous leukemia; CLL; chronic lymphocytic leukemia; ALL; acute lymphoblastic leukemia; EGF; epidermal growth factor;
Keywords: ABC; activated-B Cell; BTK; Bruton's tyrosine kinase; CNS; Central nervous system; CLL; chronic lymphocytic leukemia; DLBCL; Diffuse Large B-cell lymphoma; DAB; diaminobenzidin; DNMT; DNA methyltransferase; GO; gene ontology; GCB; germinal center cell lik
Keywords: AML; acute myeloid leukemia; DFS; disease-free survival; DLBCL; diffuse large B-cell lymphoma; DSPC; 1,2-distearoyl-sn-glycero-3-phosphocholine; DSPE; 1,2-distearoyl-sn-glycero-3-phosphoethanolamine; EPR; enhanced permeation and retention; MB; molecular b
Keywords: Encephalitis; Herpes simplex; Oncovirus; Primary central nervous system lymphoma; CNS; Central nervous system; DLBCL; Diffuse large B cell lymphoma; EBV; Epstein-Barr virus; HIV; Human immunodeficiency virus; HSV; Herpes simplex virus; PCNSL; Primary cent
Keywords: Breast cancer survivability study; SEER data; Machine learning; AJCC; American Joint Committee on Cancer; ALL-AML; Acute Lymphocytic leukemia and Acute Myeloid Leukemia; ANN; artificial neural networks; DBSCAN; density-based clustering algorithm; DLBCL; d
Keywords: DLBCL; Diffuse large B cell lymphoma; POL; Primary ovarian lymphoma; GCB; Germinal center B-cell subtype; ABC; Activated B-cell subtype; FC; Flow cytometry; IHC; Immunohistochemistry; NGS; Next generation sequencing;
Keywords: BMB; bone marrow biopsy; CNS; central nervous system; CT; contrast enhanced computed tomography; DLBCL; diffuse large B-cell lymphoma; EBV; epstein Barr virus; FDG; 18F-flurodeoxyglucose; MRI; magnetic resonance imaging; MTV; metabolic tumor volume; NPV;
Keywords: DLBCL; diffuse large B-cell lymphoma; R-CHOP; rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone; NHL; non-Hodgkin lymphoma; GEP; gene expression profiling; COO; cell-of-origin; GCB; germinal center B-cell; ABC; activated B-cell; PMBL;
Keywords: Teratoma; ovarian neoplasm; lymphoma; CT; Computed tomography; DLBCL; diffuse large B-cell lymphoma; DLBCL-CI; diffuse large B-cell lymphoma associated with chronic inflammation; PET; positron emission tomography; R-CHOP; rituximab, cyclophosphamide, hydr
Keywords: (B-)LBL; (B-cell) lymphoblastic lymphoma; DHL; double-hit lymphoma; DLBCL; diffuse large B-cell lymphoma; FFPE; formalin fixed and paraffin embedded; FISH; fluorescent in situ hybridization; FL; follicular lymphoma; IgH; immunoglobulin heavy chain; IgL; i
Keywords: γc; common gamma chain, CD132; IL; interleukin; sγc; soluble form of common gamma chain; JAK; Janus-activated kinase; STAT; signal transducer and activator of transcription; T-ALL; T-cell acute lymphocytic leukemia; B-ALL; B-cell acute lymphocytic leuke
Keywords: ALK; anaplastic lymphoma kinase; CTLs; cytotoxic T lymphocytes; DLBCL; diffuse large B-cell lymphoma; ECOG-PS; Eastern Cooperative Oncology Group Performance Status; mAb; monoclonal antibody; NSCLC; non-small cell lung cancer; non-SQC; non-squamous cell l
Keywords: PCR; polymerase chain reaction; DLBCL; diffuse large B-cell lymphoma; SMZL; splenic marginal zone lymphoma; WHO; World Health Organization; NHL; non-Hodgkin lymphoma; RLH; reactive lymphoid hyperplasia; CT; computed tomography; Cytogenetics; Lymph node; L
Keywords: CR; Complete remission; DLBCL; Diffuse large B-cell lymphoma; DNA; Deoxyribonucleic acid; EMZL; Extranodal marginal zone lymphoma; IF; Immunofluorescence; IFRT; Involved field radiotherapy; IHC; Immunohistochemistry; MALT; Mucosa associated lymphoid tissu
Keywords: DLBCL; diffuse large B cell lymphoma; GM-CSF; granulocyte macrophage colony-stimulating factor; IFN-γ; interferon γ; IL; interleukin; IP-10; IFN-γ induced protein-10; KC-like; keratinocyte chemoattractant-like; MCP-1; monocyte chemoattractant protein-1
Keywords: ADCs; antibody-drug-conjugates; ALL; acute lymphocytic leukemia; AML; acute myeloid leukemia; B-NHL; B-cell non-Hodgkin's lymphoma; ccRCC; clear cell renal cell carcinoma; DLBCL; diffuse large B-cell lymphoma; DAR; drug to antibody ratio; ECM; extra cellu
Keywords: BMI; body mass index; Cas; cases; CLL; chronic lymphocytic leukaemia; ctrl; controls; DLBCL; diffuse large B-cell lymphoma; EPIC; European prospective investigation of diet and cancer; FL; follicular lymphoma; HCAs; heterocyclic amines; HL; Hodgkin lympho
Keywords: Hematologic malignancy; Hypereosinophilia; Hypereosinophilic syndrome; Lymphoma; Leukemia; AICL; Angioimmunoblastic T-cell leukemia; AML; Acute myelogenous leukemia; ATLL; Adult T-cell lymphoma/leukemia; BE; Blood eosinophilia; CEL; Chronic eosinophilic l
Keywords: CHOP; cyclophosphamide, hydroxydaunorubicin, oncovin (vincristine), and prednisone; CMV; cytomegalovirus; DLBCL; diffuse large B-cell lymphoma; EBV; Epstein-Barr virus; HLH; hemophagocytic lymphohistiocytosis; NK; natural killer; OS; overall survival; PCR
Keywords: IL-10; interleukin-10; DLBCL; diffuse large B-cell lymphoma; SNPs; single nucleotide polymorphisms; HWE; Hardy-Weinberg equilibrium; CI; confidence interval; OR; odds ratio; et al.; et alia; NHL; non-Hodgkin's lymphoma; MAF; minor allele frequency; AS-P
Long noncoding RNAs act as regulators of autophagy in cancer
Keywords: lncRNA; long noncoding RNA; miRNA; microRNA; EMT; epithelial-mesenchymal transition; Atg; autophagy-related gene; HOTAIR; HOX antisense intergenic RNA; HCC; hepatocellular carcinoma; HULC; highly upregulated liver cancer; MALAT1; metastasis-associated lun
Role of radiotherapy in patients with limited diffuse large B-cell lymphoma of Waldeyer's ring in remission after R-CHOP immunochemotherapy
Keywords: WR; Waldeyer's ring; NHL; non-Hodgkin's lymphoma; DLBCL; diffuse large B-cell lymphoma; RT; radiotherapy; IFRT; Involved field radiation therapy; CT; immunochemotherapy; PET-CT; positron emission tomography-computed tomography; DFS; disease free survi
MYD88 L265P mutation promoted malignant B cell resistance against T cell-mediated cytotoxicity via upregulating the IL-10/STAT3 cascade
Keywords: DLBCL; IL-10; MYD88; STAT3;
Characterizing Autoimmune Disease-associated Diffuse Large B-cell Lymphoma in a SEER-Medicare Cohort
Keywords: DLBCL; Non-Hodgkin lymphoma; Rheumatoid arthritis; Sjögren syndrome; Systemic lupus erythematosus;
Down-regulated miR-148b increases resistance to CHOP in diffuse large B-cell lymphoma cells by rescuing Ezrin
Keywords: DLBCL; CHOP resistance; MiR-148b; Ezrin; HDAC6;
F-box protein 11 promotes the growth and metastasis of gastric cancer via PI3K/AKT pathway-mediated EMT
Keywords: GC; gastric cancer; FBXO11; F-box protein 11; DLBCL; diffuse large B-cell lymphoma; CRC; colorectal cancer; HIF-1α; hypoxia-inducible factor-1α; EMT; epithelial-mesenchymal transition; PTEN; phosphatase and tensin homolog; PI3K; phosphotidylinsitol-3-ki
Consolidative Radiotherapy After Autologous Stem Cell Transplantation for Relapsed or Refractory Diffuse Large B-cell Lymphoma
Keywords: ASCT; DLBCL; Involved-field radiotherapy; Locoregional control; Residual mass;
Utility of Left Ventricular Ejection Fraction Measurements Before the Administration of Doxorubicin-Based Chemotherapy in Patients With Diffuse Large B-Cell Lymphoma
Keywords: AHA; American Heart Association; CD; cardiac disease; CHF; congestive heart failure; DLBCL; diffuse large B-cell lymphoma; DOX; doxorubicin-based chemotherapy; LVEF; left ventricular ejection fraction; MUGA; multiple-gated acquisition;
Metabolomic Profiling Reveals Cellular Reprogramming of B-Cell Lymphoma by a Lysine Deacetylase Inhibitor through the Choline Pathway
Keywords: DLBCL; Metabolomics; Panobinostat; Choline pathway; PI3K;
Immune Characteristics of Chinese Diffuse Large B-Cell Lymphoma Patients: Implications for Cancer Immunotherapies
Keywords: DLBCL; Cell of origin; Immune characteristics; Immunotherapy;
CD45 in human physiology and clinical medicine
Keywords: AD; Alzheimer disease; ALL; acute lymphocytic leukemia; APC; antigen presenting cell; BMHSC; bone marrow hematopoietic stem cell; CLL; chronic lymphocytic leukemia; DLBCL; diffuse large B cell lymphoma; IS; immunological synapse; MGL; macrophage galactose
Treatment strategies and outcomes in diffuse large B-cell lymphoma among 1011 patients aged 75 years or older: A Danish population-based cohort study
Keywords: DLBCL; Elderly; Comorbidity and treatment; Chemotherapy; R-CHOP;
Optimization of permeability in a series of pyrrolotriazine inhibitors of IRAK4
Keywords: ABC; Activated B Cell-like; BTK; Bruton's Tyrosine Kinase; CD79; Cluster of Differentiation 79; CDK; Cyclin Dependent Kinase; CLK; CDC-Like Kinase; DCM; dichloromethane; DDQ; 2,3-Dichloro-5,6-DicyanobenzoQuinone; DIPEA; N,N-diisopropylethylamine; DLBCL;
An Open-label, Phase II Trial of Entospletinib (GS-9973), a Selective Spleen Tyrosine Kinase Inhibitor, in Diffuse Large B-cell Lymphoma
Keywords: B-cell receptor signaling inhibitors; DLBCL; Hematologic malignancies; Monotherapy; Syk;
GESIDA/PETHEMA recommendations on the diagnosis and treatment of lymphomas in patients infected by the human immunodeficiency virus
Keywords: ABC; abacavir; ABVD; adriamycin, bleomycin, vinblastine and dacarbazine; Ara-C; cytosine arabinoside; AZT; zidovudine; BCNU; carmustine; BEACOPP; bleomycin, etoposide, adriamycin, cyclophosphamide, vincristine, procarbazine and prednisone; CDC; Centers fo
Andrographolide, a diterpene lactone from Andrographis paniculata and its therapeutic promises in cancer
Keywords: Andrographolide; Andrographis paniculata; Diterpene lactone; Anticancer; Chemotherapy; Bioactive lactone; ACS; American Chemical Society; AKT; activated protein kinase; Andro; Andrographolide derivative or conjugate; AP-1; activator protein-1; Cdk; Cyclin
MyD88 Mutation in Elderly Predicts Poor Prognosis in Primary Central Nervous System Lymphoma: Multi-Institutional Analysis
Keywords: Central nervous system lymphoma; Elderly; Genetic change; MyD88 mutation; Prognostic factor; CI; Confidence interval; CrCl; Creatinine clearance; DLBCL; Diffuse large B cell lymphoma; HR; Hazard ratio; OS; Overall survival; PCNSL; Primary central nervous
Targeting the B-cell receptor pathway in diffuse large B-cell lymphoma
Keywords: B-cell receptor signaling; BTK; PI3K; PCNSL; DLBCL;
Synthesis and structure-activity relationship studies of MI-2 analogues as MALT1 inhibitors
Keywords: NHL; non-Hodgkin lymphoma; DLBCL; diffuse large B-cell lymphoma; ABC-DLBCL; the activated B cell-like DLBCL; MALT1; mucosa-associated lymphoid tissue protein-1; NF-кB; nuclear factor кB; CARMA1; CARD-containing MAGUK protein 1 (CARD11, caspase recruitme
NF-κB in the crosshairs: Rethinking an old riddle
Keywords: BCL-2; B-cell lymphoma 2; BCL-XL; B-cell lymphoma-extra large; BFL-1; Bcl-2-related gene expressed in foetal liver; cIAP; cellular inhibitor of apoptosis; cFLIP; cellular FLICE-inhibitory protein; CLL; chronic lymphocytic leukaemia; DIABLO; direct inhibit
A Phase II Trial of Bortezomib and Vorinostat in Mantle Cell Lymphoma and Diffuse Large B-cell Lymphoma
Keywords: Clinical trial; DLBCL; Histone deacetylase inhibitor; MCL; Proteasome inhibitors;
Stereotactic Brachytherapy with Iodine-125 Seeds Plus Temozolomide Induced Complete and Durable Remission in a Patient with Recurrent Primary Central Nervous System Lymphoma
Keywords: Iodine-125 seeds; Primary central nervous system lymphoma; Recurrent stereotactic brachytherapy; Temozolomide; 125-I; Iodine-125; DLBCL; Diffuse large B-cell lymphoma; HD-MTX; High-dose methotrexate; MGMT; O6-Methylguanine-DNA methyl-transferase; MRI; Mag
Elevated miR-20b-5p expression in peripheral blood mononuclear cells: A novel, independent molecular biomarker of favorable prognosis in chronic lymphocytic leukemia
Keywords: AUC; area under the curve; BCa; bias corrected and accelerated; CI; confidence interval; CLL; chronic lymphocytic leukemia; DLBCL; diffuse large B-cell lymphoma; HIF1A; hypoxia-inducible factor 1 alpha subunit; IGHV; immunoglobulin heavy chain variable re
Identification of key microRNAs associated with diffuse large B-cell lymphoma by analyzing serum microRNA expressions
Keywords: DLBCL; diffuse large B-cell lymphoma; DEMs; Differentially expressed miRNAs; KEGG; Kyoto Encyclopedia of Genes and Genomes; PPI; protein-protein interaction; qRT-PCR; quantitative reverse transcription polymerase chain reaction; TP53; tumor protein p53;
Prognostication of diffuse large B-cell lymphoma in the molecular era: moving beyond the IPI
Keywords: DLBCL; Prognosis; Lymphoma biology; Cell of origin;
Antibody-drug conjugates (ADCs): Potent biopharmaceuticals to target solid and hematological cancers- an overview
Keywords: Antibody-drug conjugates; Monoclonal antibodies; Anticancer; Drug resistance; Solid tumors; Hematological tumors; ADC; Antibody-Drug Conjugate; ALCL; Anaplastic Large Cell Lymphoma; ALL; Acute Lymphoblastic Leukemia; AML; Acute Myeloid Leukemia; BCMA; B C
Autophagy as a pharmacological target in hematopoiesis and hematological disorders
Keywords: 3-MA; 3-methyladenine; ALL; acute lymphoblastic leukemia; AMKL; acute megakaryoblastic leukemia; AML; acute myeloid leukemia; AMPK; 5â²-adenosine monophosphate-activated protein kinase; APL; acute promyelocytic leukemia; Atg; autophagy-related proteins;